Home›Search›Epitheorese Klinikes Farmakologias kai Farmakokinetikes

Epitheorese Klinikes Farmakologias kai Farmakokinetikes

PHARMAKON-Press · Greece

ISSN1011-6575

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.108

H-Indexi

SNIPi

0.103

Total Worksi

Total Citationsi

2yr Mean Citednessi

0.17

Open Impact Factor alternative

Aims & Scope

Subject areas: Pharmacology; Pharmacology (medical).

General Information

Country / RegionGreece

Primary Language—

1st Year Published—

Annual Volume~ 20 articles / year

StatusActive

Total Publications58

Submission Info

Publishing ModelSubscription

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

PHARMAKON-Press

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

1011-6575

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

PharmacologyQ4

Pharmacology (medical)Q4

Subject Classification

Scopus Categories

PharmacologyPharmacology (medical)

Research Topics (OpenAlex)

COVID-19 Clinical Research StudiesNeuroscience and Neuropharmacology ResearchBlood Pressure and Hypertension StudiesEssential Oils and Antimicrobial ActivityOral microbiology and periodontitis researchVitamin D Research StudiesPregnancy and preeclampsia studiesThyroid Disorders and TreatmentsLiver Disease Diagnosis and TreatmentPharmaceutical Practices and Patient Outcomes

Frequently asked questions about Epitheorese Klinikes Farmakologias kai Farmakokinetikes

Is Epitheorese Klinikes Farmakologias kai Farmakokinetikes a predatory journal?

PubScope has no integrity flags on record for Epitheorese Klinikes Farmakologias kai Farmakokinetikes: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Epitheorese Klinikes Farmakologias kai Farmakokinetikes?

Epitheorese Klinikes Farmakologias kai Farmakokinetikes is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.108.

Is Epitheorese Klinikes Farmakologias kai Farmakokinetikes indexed in Scopus and Web of Science?

Epitheorese Klinikes Farmakologias kai Farmakokinetikes is indexed in Scopus.

What is the aims and scope of Epitheorese Klinikes Farmakologias kai Farmakokinetikes?